Autologous fat grafting in the treatment of fibrotic perioral changes in patients with systemic sclerosis

Cell Transplantation

Volumn 24, Issue 1, 2015, Pages 63-72

  Del Papa, Nicoletta ^a   Caviggioli, Fabio ^b   Sambataro, Domenico ^a   Zaccara, Eleonora ^a   Vinci, Valeriano ^c   Luca, Gabriele Di ^a   Parafioriti, Antonina ^a   Armiraglio, Elisabetta ^a   Maglione, Wanda ^a   Polosa, Riccardo ^d   Klinger, Francesco ^b   Klinger, Marco ^c  

^a ISTITUTO ORTOPEDICO GAETANO PINI   (Italy)

^b IRCCS MULTIMEDICA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

Author keywords

Adipose tissue; Autologous graft; Stem cells; Systemic sclerosis (SSc)

Indexed keywords

ADULT; ARTICLE; CAPILLARY; CLINICAL ARTICLE; COMPOSITE SKIN GRAFT; DISEASE DURATION; FEMALE; HARDNESS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIP; MEDICAL DEVICE; MOUTH; MOUTH MALFORMATION; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; SKIN BIOPSY; SKIN STRUCTURE; SYSTEMIC SCLEROSIS; TISSUE SECTION; UMBILICUS; ADIPOSE TISSUE; AUTOGRAFT; CLINICAL TRIAL; MIDDLE AGED; MOUTH DISEASES; MULTICENTER STUDY; PATHOLOGY; PATHOPHYSIOLOGY; SCLERODERMA, SYSTEMIC; TRANSPLANTATION; VASCULARIZATION;

ADIPOSE TISSUE; ADULT; AUTOGRAFTS; CAPILLARIES; FEMALE; HUMANS; LIP; MIDDLE AGED; MOUTH DISEASES; SCLERODERMA, SYSTEMIC;

EID: 84921793087     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368914X674062     Document Type: Article

References (43)

1. Abrahamsson, S.; Muraro, P. A. Immune re-education following autologous hematopoietic stem cell transplantation. Autoimmunity 41:577–584; 2008
2. Barry, F. P.; Murphy, J. M.; Mesenchymal stem cells: Clinical applications and biological characterization. Int. J. Biochem. Cell Biol. 36:568–584; 2004
3. Beyer, C.; Distler, O.; Distler, J. H. Innovative antifibrotic therapies in systemic sclerosis. Curr. Opin. Rheumatol. 24: 274–280; 2012
4. Bhattacharyya, S.; Wei, J.; Varga, J. Understanding fibrosis in systemic sclerosis: Shifting paradigms, emerging opportunities. Nat. Rev. Rheumatol. 8:42–54; 2011
5. Burt, R. K.; Shah, S. J.; Dill, K.; Grant, T.; Gheorghiade, M.; Schroeder, J.; Craig, R.; Hirano, I.; Marshall, K.; Ruderman, E.; Jovanovic, B.; Milanetti, F.; Jain, S.; Boyce, K.; Morgan, A.; Carr, J.; Barr, W. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): An open-label, randomised phase 2 trial. Lancet 378:498–506; 2011
6. Caviggioli, F.; Maione, L.; Vinci, V.; Klinger, M. The most current algorithms for the treatment and prevention of hypertrophic scars and keloids. Plast. Reconstr. Surg. 126: 1130–1131; 2010
7. Chaffee, N. R. CREST syndrome: Clinical manifestations and dental management. J. Prosthod. 7:155–160; 1998
8. Clauser, L.; Tieghi, R.; Consorti, G. Parry-Romberg syndrome: Volumetric regeneration by structural fat grafting technique. J. Craniomaxillofac. Surg. 38:605–609; 2010
9. Coleman, S. R. Structural fat grafting: More than a permanent filler. Plast. Reconstr. Surg. 118(3 Suppl):108S–120S; 2006
10. Conforti, G.; Tieghi, R.; Clauser, L. C. Frontal linear scleroderma: Long-term result in volumetric restoration of the fronto-orbital area by structural fat grafting. J. Craniofacial Surg. 23:263–264; 2012
11. Fang, F.; Liu, L.; Yang, Y.; Tamaki, Z.; Wie, J.; Marangoni, R. G.; Bhattacharyya, S.; Summer, R. S.; Ye, B.; Varga, J. The adipokine adiponectin has potent antifibrotic effects mediated via adenosine monophosphateactivated protein kinase: Novel target for fibrosis therapy. Arthritis Res. Ther. 14(5):R229; 2012
12. Farge, D.; Gluckman, E. Autologous HSCT in systemic sclerosis: A step forward. Lancet 378:460–462; 2011
13. Fleming, J. N.; Nash, R. A.; McLeod, D. O.; Fiorentino, D. F.; Shulman, H. M.; Connolly, M. K.; Molitor, J. A.; Hensotrf, G.; Lafyatis, R.; Pritchard, D. K.; Adams, L. D.; Furst, D. E.; Schwartz, S. M. Capillary regeneration in scleroderma: Stem cell therapy reverses phenotype? PLoS One 3:e1452; 2008
14. Gimble, J. M.; Katz, A. J.; Bunnel, B. A. Adipose-derived stem cells for regenerative medicine. Circ. Res. 100:1249–1260; 2007
15. Hachulla, E.; Launay, D. Diagnosis and classification of systemic sclerosis. Clin. Rev. Allergy Immunol. 40:78–83; 2011
16. Hsu, V. M.; Stransky, C. A.; Bucky, L. P.; Percec, I. Fat grafting’s past, present, and future: Why adipose tissue is emerging as a critical link to the advancement of regenerative medicine. Aesthet. Surg. J. 32(7):892–899; 2012
17. Karaaltin, M. V.; Akpinar, A. C.; Baghaki, S.; Akpinar, F. Treatment of “En coup de sabre” deformity with adiposederived regenerative cell-enriched fat graft. J. Craniofacial Surg. 23(2):e103–e105; 2012
18. Lapierre, J. C.; Aasi, S.; Cook, B.; Montalvo, A. Successful correction of depressed scars of the forehead to trauma and morphea en coup de sabre by en bloc autologous dermal fat graft. Dermatol. Surg. 26:793–796; 2000
19. Lee, S. K.; Kim, D. W.; Dhong, E. S.; Park, S. H.; Yoon, E. S. Facial soft tissue augmentation using autologous fat mixed with stromal vascular fraction. Arch. Plast. Surg. 39: 534–539; 2012
20. LeRoy, E. C.; Black, C.; Fleischmajer, R.; Jablonska, S.; Krieg, T.; Medsger, Jr., T. A.; Rowell, N.; Wollheim, F. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J. Rheumatol. 15:202–205; 1988
21. Maddali-Bongi, S.; Landi, G.; Galluccio, F.; Del Rosso, A.; Miniati, I.; Conforti, M. L.; Casale, R.; Matucci-Cerinic, M. The rehabilitation of facial involvement in systemic sclerosis: Efficacy of the combination of connective tissue massage, Kabat’s technique and kinesitherapy: A randomized controlled trial. Rheumatol. Int. 3(7):895–901; 2011
22. Medsger, Jr., T. A. Natural history of systemic sclerosis and assessment of disease activity, severity, functional status, and psychologic well-being. Rheum. Dis. Clin. N. Am. 29: 255–273; 2003
23. Miniati, I.; Guiducci, S.; Conforti, M. L.; Rogai, V.; Fiori, G.; Cinelli, M.; Saccardi, R.; Guidi, S.; Bosi, A.; Tyndall, A.; Matucci-Cerinic, M. Autologous stem cell transplantation improves microcirculation in systemic sclerosis. Ann. Rheum. Dis. 68:94–98; 2009
24. Mizuno, H. Adipose-derived stem cells for tissue repair and regeneration: Ten years of research and a literature review. J. Nihon Med. Sch. 76:56–66; 2009
25. Nguyen, A.; Pasyk, K. A.; Bouvier, T. N. Comparative study of survival of autologous adipose tissue taken and transplanted by different techniques. Plast. Reconstr. Surg. 85:378–386; 1990
26. Niechajev, I.; Sevchuk, O. Long-term results of fat transplantation: Clinical and histologic studies. Plast. Reconstr. Surg. 94:496–506; 1994
27. Ong, V. H.; Denton, C. P. Innovative therapies for systemic sclerosis. Curr. Opin. Rheumatol. 22:264–272; 2010
28. Poloni, A.; Maurizi, G.; Leoni, P.; Serrani, F.; Mancini, S.; Frontini, A.; Zingaretti, M. C.; Siquini, W.; Sarzani, R.; Cinti, S. Human dedifferentiated adipocytes show similar properties to bone marrow-derived mesenchymal stem cells. Stem Cells 30:965–974; 2012
29. Quillinan, N. P.; Denton, C. P. Disease-modifying treatment in systemic sclerosis: Current status. Curr. Opin. Rheumatol. 21:636–641; 2009
30. Ramos-Casals, M.; Fonollosa-Pla, V.; Brito-Zerón, P.; Sisó-Almirall, A. Targeted therapy for systemic sclerosis: How close are we? Nat. Rev. Rheumatol. 6:269–278; 2010
31. Ren, G.; Chen, X.; Dong, F.; Li, W.; Ren, X.; Zhang, Y.; Shi, Y. Concise review: Mesenchymal stem cells and translational medicine: Emerging issues. Stem Cells Transl. Med. 1:51–58; 2012
32. Rigotti, G.; Marchi, A.; Galié, M.; Baroni, G.; Benati, D.; Krampera, M.; Pasini, A.; Sbarbati, A. Clinical treatment of radiotherapy tissue damages by lipoaspirates transplant: A healing process mediated by adipose derived stem cells. Plast. Reconstr. Surg. 119:1409–1422; 2007
33. Roh, M. R.; Jung, J. Y.; Chung, K. Y. Autologous fat transplantation for depressed linear scleroderma-induced facial atrophic scars. Dermatol. Surg. 34:1659–1665; 2008
34. Salgarello, M.; Visconti, G.; Barone-Adesi, L. Fat grafting and breast reconstruction with implant: Another option for irradiated breast cancer patients. Plast. Reconstr. Surg. 129: 317–329; 2012
35. Scuderi, N.; Ceccarelli, S.; Onesti, M. G.; Fieramonti, P.; Guidi, C.; Romano, F.; Frati, L.; Angeloni, A.; Marchese, C. Human adipose-derived stem cells for cell-based therapies in the treatment of systemic sclerosis. Cell Transplant. 22(5):779–795; 2013
36. Shouffer, A. A.; Ninaber, M. K.; Beaart-Van De Voorde, L. J. J.; Van Der Giesen, F. J.; De Jong, Z.; Stolk, J.; Voskuyl, A. E.; Scherptong, R. W. C.; Van Laar, J. M.; Schuerwegh, A. J. M.; Huizinga, T. W. J.; Vliet Vlieland, T. P. M. Randomized comparison of a multidisciplinary team care program with usual care in patients with systemic sclerosis. Arthritis Care Res. 63(6):909–917; 2011
37. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 23:581–590; 1980
38. Takahashi, M. Adipose tissue: An alternative source for therapeutic angiogenesis. Circ. J. 76:1597–1598; 2012
39. Tyndall, A.; Uccelli, A. Multipotent mesenchymal stromal cells for autoimmune diseases: Teaching new dogs old tricks. Bone Marrow Transplant. 43:821–828; 2009
40. van Laar, J. M.; Farge, D.; Sont, J. K.; Naraghi, K.; Marjanovic, Z.; Schuerwegh, A. J. The ASTIS trial: Autologous stem cell transplantation versus IV pulse cyclophosphamide in poor prognosis systemic sclerosis, first results. Ann. Rheum. Dis. 71(Suppl 3):15; 2012
41. Yañez, R.; Lamina, M. L.; García-Castro, J.; Colmenero, I.; Ramírez, M.; Bueren, J. A. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 12:3375–3382; 2006
42. Yi, T.; Song, S. U. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications. Arch. Pharm. Res. 35:213–221; 2012
43. Zuk, P. A.; Zhu, M.; Mizuno, H.; Huang, J.; Futrell, J. W.; Katz, A. J.; Benhaim, P.; Lorenz, H. P.; Hedrick, M. H. Multilineage cells from human adipose tissue: Implication for cell-based therapies. Tissue Eng. 7:211–228; 2001.